Session 4: Monitoring and Evaluation

Pharmaceutical management, Information, Clinical trials, Comparison and Current Studies about malaria drugs
jufel
Posts: 41
Joined: Mon Aug 01, 2016 4:22 am

Session 4: Monitoring and Evaluation

Postby jufel » Sat Aug 06, 2016 7:34 am

Topic originally started by Joseph Yap from the old forum.
----------------------------------------------------------------------

Please find the attached refresher course for session 4: Monitoring and Evaluation.

Here is the question for session 4: Have you developed indicators to evaluate performance of the pharmaceutical management system for antimalarials?

All participants responding to all sessions will have the chance to qualify for the reward.

Thank you.

Originally posted by aton_cabugayan from the old forum.
--------------------------------------------------------------------


Dear Sharri,

Regarding the monitoring and evaluation we only have one major indicator to monitor the performance of the pharmaceutical management and that is the # of health facilities report no stock out. I have attached here the sample monitoring template.

Your comment on the said form is highly appreciated.

Aton

Originally posted by Sharri_Hollist from the old forum.
-----------------------------------------------------------------


Yes, we have done. They are include:
- Percentage of antimalarials available (not expired) at the time of data collection.
- Malaria confirmed cases.
- Rate of malaria cases infected P. falciparum and P. vivax.
- Percentage of antimalarial drugs storage facilities with expired medicines at the time of the last supervisory visit.


Yours faithlully,
Nguyen Thi Minh Thu

Originally posted by Kathy Webb from the old forum.
-----------------------------------------------------------------


Summary of responses:

Both countries that responded have put in place at least one indicator to measure and monitor performance of the pharmaceutical management system. In both countries the indicators look at availability of antimalarials or essential medicines.

Issues to consider:

It is important to clearly define the list of medicines (tracer list) for which the indicators will be monitored and calculated. The stock out indicator (conversely, the availability indicator) is a good one as health service providers are unable to treat cases of malaria without medicines. Depending on how this indicator is written and the frequency of data collection or reporting it can give you either a snapshot of availability at a given point in time (i.e. at the time of supervision visit) or you may have data on stock-outs or availability over time to potentially identify recurrent problems.

An indicator that monitors the quality of record-keeping can provide useful information on the capacity of staff responsible for management of antimalarial and essential medicines. Poor inventory management and record-keeping can be a factor that affects medicine availability. Such an indicator can also give an idea of the quality of record-keeping, which can also indicate the quality of data regularly reported from that site.

An example of such an indicator is: Average percentage of stock records that correspond with
physical counts for a set of antimalarial medicines in MOH storage and health facilities.
Attachments
Report_Summary_Template_080508.rar
(123.5 KiB) Downloaded 112 times

Who is online

Users browsing this forum: No registered users and 1 guest